Increase and plateau orf CD4 T-cell counts in the 3-1/2 years after initiation of potent antiretroviral therapy
Article Abstract:
Highly active antiretroviral therapy (HAART) will decrease viral levels and increase CD4 T cell count, but only up to a certain point. About three years after treatment starts, both viral levels and CD4 T cell counts reach a plateau and don't change any further.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
Effectiveness of Potent Antiretroviral Therapy on Time to AIDS and Death in Men With Known HIV Infection Duration
Article Abstract:
Potent antiretroviral drugs have significantly delayed the progression of HIV infection to AIDS, and improved the survival of HIV patients. Researchers compared 536 patients who contracted HIV from 1984 to 1997. Early HIV treatment was with a single drug, such as zidovudine, while patients infected later used combined drug therapy and, recently, potent antiretroviral drugs. Patients treated with antiretroviral drugs progressed to AIDS later than those given monotherapy or combined drug therapy, and patients on antiretroviral agents had slower declines in CD4 white blood cell counts.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals
Article Abstract:
The authors explore the relationship between the use of antiretroviral therapy for HIV-infected patients and the incidence of either Kaposi's sarcoma (KS) or non-Hodgkin's lymphoma (NHL). They found that the incidence of KS had declined significantly but that cases of NHL continued to rise.
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Impact of highly active antiretroviral therapy on anemia and relationship between anemia and survival in a large cohort of HIV-infected women: women's interagency HIV study.
- Abstracts: Impact of Folic Acid Fortification of the US Food Supply on the Occurrence of Neural Tube Defects. Food Fortification to Prevent Neural Tube Defects: Is It Working?
- Abstracts: Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: Results of AIDS clinical trials group 5108 study
- Abstracts: Survival after AIDS-defining events in patients with fewer than 200 lymphocytes CD4+ x 10(super)6/L who are toxoplasmosis antibody positive